Read + Share
Amedeo Smart
Independent Medical Education
Uppal M, Joseph A, Drill E, Hamlin P, et al. Predictors of outcomes with covalent BTK inhibitor treatment in relapsed/refractory TP53-mutant mantle cell lymphoma. Br J Haematol 2025 Jun 23. doi: 10.1111/bjh.20202.PMID: 40551465
Email
LinkedIn
Privacy Policy